Table 1.

Sensitivity to carbonyl cyanide m-chlorophenylhydrazone (mCICCP); bcl-2, bax, and bcl-x expression; and p53 status in 16 samples from patients with acute myeloblastic leukemia

Patient no.mClCCP IC50Mean bcl2 (BFM × 105)Mean bax (BFM × 106)Mean bcl-x (BFM × 105)p53 status
154R 3.1 2.7 6.1 wt 
16 10 0.54 1.5 3.9 wt 
161 0.81 1.2 3.4 wt 
145 10 2.0 2.3 5.5 wt 
139 0.98 0.5 2.4 wt 
178 4.6 7.8 3.5 wt 
179 1.4 2.2 2.1 wt 
71 2.6 2.9 Failed wt 
177 1.4 1.8 2.9 wt 
71 10 0.54 0.57 1.1 273cgt-cat 
136 0.29 0.16 0.91 249agg-tgg 
157 10 2.3 1.6 1.9 273cgt-cat 
95 0.66 0.43 1.8 wt 
184 11 1.26 2.74 2.2 Not done 
134 3.1 2.3 1.7 Not done 
76 2.7 0.97 2.66 Not done 
Patient no.mClCCP IC50Mean bcl2 (BFM × 105)Mean bax (BFM × 106)Mean bcl-x (BFM × 105)p53 status
154R 3.1 2.7 6.1 wt 
16 10 0.54 1.5 3.9 wt 
161 0.81 1.2 3.4 wt 
145 10 2.0 2.3 5.5 wt 
139 0.98 0.5 2.4 wt 
178 4.6 7.8 3.5 wt 
179 1.4 2.2 2.1 wt 
71 2.6 2.9 Failed wt 
177 1.4 1.8 2.9 wt 
71 10 0.54 0.57 1.1 273cgt-cat 
136 0.29 0.16 0.91 249agg-tgg 
157 10 2.3 1.6 1.9 273cgt-cat 
95 0.66 0.43 1.8 wt 
184 11 1.26 2.74 2.2 Not done 
134 3.1 2.3 1.7 Not done 
76 2.7 0.97 2.66 Not done 

IC50 indicates the dose of mCICCP which induces 50% loss of mitochondrial membrane potential; BFM, bound fluorochrome molecules.

Correlation coefficients (Spearman ρ for mClCCP IC50 with bcl family expression) were −0.172 for bcl2, 0.178 for bax, and −0.282 for bcl-x; none of these correlations were significant at theP < .05 level.

Close Modal

or Create an Account

Close Modal
Close Modal